Pancreaticoduodenectomy in the era of evidence based medicine;La duodénopancréatectomie céphalique à l'ère de la médecine factuelle

Annales de Chirurgie

Volumn 130, Issue 5, 2005, Pages 295-302

  Sastre, B ^a   Ouassi, M ^a   Pirro, N ^a   Cosentino, B ^a   Sielezneff, I ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Evidence based medicine; Pancreatic cancer; Pancreaticoduodenectomy; Surgery

Indexed keywords

OCTREOTIDE;

CANCER MORTALITY; CANCER SURVIVAL; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LYMPHADENECTOMY; MORBIDITY; PANCREAS CANCER; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; PYLORUS; REVIEW; STENT; STOMACH EMPTYING; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; SURGICAL TRAINING; SURVIVAL RATE; VALIDATION PROCESS;

EID: 20444427267     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anchir.2004.12.005     Document Type: Short Survey

References (51)

1. L. Sauve À propos de la duod́nopancŕatectomie pour cancer de la t̂te du pancŕas Mem. Acad. Chir. (Paris) 75 1949 810 814
2. A. Whipple Treatment of carcinoma of ampulla of Vater Ann. Surg. 102 1935 763 779
3. A. Brunschwig Ŕsection de la t̂te du pancŕas et du duod́num pour cancer. Duod́nopancreatectomie Surg. Gynecol. Obstet. 65 1937 681 684
4. H. Baumel, M. Hugiuier, J. Manderscheid, J. Fabre, S. Houry, and H. Fagot Results of resection for cancer of exocrine pancreas: a study from the French Association of Surgery Br. J. Surg. 81 1994 102 107
5. M. Lieberman, H. Kilburn, M. Lindsey, and M. Brennan Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy Ann. Surg. 222 1995 638 645
6. J.P. Neoptolemos, D.D. Stocken, J.A. Dunn, J. Almond, H.G. Beger, P. Pederzoli European Study Group for Pancreatic Cancer. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann. Surg. 234 2001 758 768
7. E. Nini, K. Slim, and J. Belghiti Drainage biliaire pŕoṕ ratoire ou non avant une duod́nopancŕatectomie ćphalique? Ann. Chir. 128 2003 714 715
8. M.W. Buchler, H. Friess, M. Wagner, C. Kulli, V. Wagener, and K. Z'Graggen Pancreatic fistula after pancreatic head resection Br. J. Surg. 87 2000 883 889
9. J. Roder, H. Stein, K. Böttcher, R. Busch, C.D. Heidecke, and J.R. Siewert Stented vs nonstented pancreaticojejunostomy. A prospective study Ann. Surg. 229 1999 41 48
10. D. Grosdidier, J.P. Nesseler, P. Boissel, and J. Grosdidier Remaining pancreas after cephalic pancreaticoduodenectomy. Development and treatment J. Chir. (Paris) 119 1982 485 490
11. K. Tran, C. Van Eijck, V. Di Carlo, W. Hop, A. Zerbi, and G. Balzano Occlusion of the pancreatic duct vs pancreaticojejunostomy. A prospective randomized study Ann. Surg. 236 2002 422 428
12. B. Suc, S. Msika, M. Piccini, G. Fourtanier, J.M. Hay, Y. Flamant French Associations for Surgical Research. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection Arch. Surg. 139 2004 288 294
13. K. Slim, and J. Le Borgne Pŕvention ḿdicamenteuse des fistules pancŕatiques apr̀s duod́nopancŕatectomie ćphalique Ann. Chir. 128 2003 175 176
14. M. Büchler, H. Friess, I. Klempa, P. Hermanek, U. Sulkoxski, and H. Becker Role of octreotide in the prevention of postoperative complications following pancreatic resection Am. J. Surg. 163 1992 125 130
15. P. Pederzoli, C. Bassi, M. Falconi, and M.G. Camboni Efficacy of octreotide in the prevention of complications of elective pancreatic surgery: Italian Study Group Br. J. Surg. 81 1994 265 269
16. M. Montorsi, M. Zago, F. Mosca, F. Mosca, L. Capussotti, and E. Zotti Efficacy of octreotide in the prevention of pancreati fistula after elective pancreatic resections: a prospective controlled randomized clinical trial Surgery 117 1995 26 31
17. A. Lowy, J. Lee, P. Pisters, B. Davidson, C. Fenoglio, and P. Stanford Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease Ann. Surg. 226 1997 632 641
18. C.J. Yeo, J.L. Cameron, K.D. Lillemoe, P.K. Sauter, J. Coleman, and T.A. Sohn Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Ann. Surg. 232 2000 419 429
19. H.S.B.H. Friess, U. Sulkowski, H. Becker, B. Hofbauer, H.J. Dennler, and M.W. Buchler Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis Br. J. Surg. 82 1995 1270 1273
20. A. Stojadinovic, A. Brooks, A. Hoos, D. Jacques, K. Colon, and M. Brennan An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma J. Am. Coll. Surg. 196 2003 954 964
21. J. Li-Ling, and M. Irving Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials Br. J. Surg. 88 2001 190 199
22. C. Yeo, J. Cameron, M. Maher, P. Sauter, M. Zahurak, and M. Talamini A prospective randomized trial of pancreaticogastrostomy vs pancreaticojejunostomy after pancreaticoduodenectomy Ann. Surg. 222 1995 580 592
23. E. Lemaire, D. O'toole, A. Sauvannet, P. Hammel, J. Belghiti, and P. Ruzniewski Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis Br. J. Surg. 87 2000 434 438
24. P. Lin, and Y.J. Lin Prospective randomized comparaison between pylorus-preserving and standard pancreaticoduodenectomy (Whipple procedure): initial clinical results Br. J. Surg. 86 1999 603 607
25. C.A. Seiler, M. Wagner, C. Sadowski, C. Kulli, and M.W. Buchler Randomized prospective trial of pylorus-preserving vs classic duodenopancreatectomy (Whipple procedure): Initial clinical results J. Gastrointest. Surg. 4 2000 443 452
26. K.T. Tran, H.G. Smeenk, C.H. Van Eijck, G. Kazemier, W.C. Hop, and J.W. Greve Pylorus preserving pancreaticoduodenectomy vs standard whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors Ann. Surg. 240 2004 738 745
27. P. Ducrotte, I. Leblanc-Louvry, and P. Michel Quality of life after gastrectomy and cephalic duodenopancreatectomy Gastroenterol. Clin. Biol. 24 2000 B24 B30
28. D.R. Hunt, and R. Mc Lean Pylorus-preserving pancreatectomy: functional results Br. J. Surg. 76 1989 173 176
29. W. Melvin, K. Bueckers, P. Muscarella, J. Johnson, W. Schirmer, and E.C. Ellison Outcome analysis of long term survivors following pancreatoduodenectomy Clin. Gastrointest. Surg. 2 1998 72 78
30. C. Yeo, K. Barry, P. Sauter, S. Sostre, K. Lillemoe, and H. Pitt Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective randomized placebo-controlled trial Ann. Surg. 218 1993 229 238
31. S. Ohwada, Y. Satoh, S. Kawate, T. Yamada, O. Kawamura, and T. Koyama Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy Ann. Surg. 234 2001 668 674
32. J. Lim, M. Chien, and C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma. A pomulation-based, kinked database analysis of 396 patients Ann. Surg. 237 2003 74 85
33. T. Sohn, C. Yeo, J. Cameron, L. Koniaris, S. Kaushal, and R. Abrams Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and pronostic indicators J. Gastrointest. Surg. 4 2000 567 579
34. J. Fortner, D. Klimstra, R. Senie, and B. Maclean Tumor size is the primary prognostic factor for pancreatic cancer after regional pancreatectomy Ann. Surg. 223 1996 147 153
35. J. Cameron, D. Crist, J. Sitzmann, R. Hruban, J. Boitnott, and A. Seidler Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer Am. J. Surg. 161 1991 120 125
36. S. Pedrazzoli, V. DiCarlo, R. Dionigi, F. Mosca, P. Pederzoli, and C. Pasquali The lymphadenectomy study group, Standard vs extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter, prospective, randomized study Ann. Surg. 228 1998 508 517
37. C. Yeo, A. Ross, L. Grochow, T. Sohn, S. Ord, and R. Hruban Pancreticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann. Surg. 225 1997 621 636
38. C.C.J. Yeo, K. Lillemoe, T. Sohn, K. Campbell, P. Sauter, and J. Coleman Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periamullary adenocarcinoma, part 2. Randomized controlled trial evaluatin survival, morbidity and mortality Ann. Surg. 236 2002 355 368
39. S. Takahashi, Y. Ogota, and T. Tsuzuki Combined resection of the pancreas and portal vein for pancreatic cancer Br. J. Surg. 81 1994 1190 1193
40. R. Van Geenen, F. Ten Fate, L. de Wit, T. Van Gülik, H. Obertop, and D. Gouma Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy Surgery 129 2001 158 163
41. G.L.S. Fuhrman, C. Staley, and J. Cusack Rationale for En Bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence Ann. Surg. 223 1996 154 162
42. J. Baulieux, M. Adham, E. Oussoultzoglou, E. De la Roche, N. Berthoux, and O. Bourdeix La pancreatectomie pour cancer avec ŕsection des vaisseaux ŕtropancreatiques est-elle justifíe? Ann. Chir. 123 1998 438 444
43. S.D. Leach, J.E. Lee, C. Charnsangavej, K.R. Cleary, A.M. Lowy, and C.J. Fenoglio Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head Br. J. Surg. 85 1998 611 617
44. D. Mutter, Y. Panis, and J. Escat Le drainage en chirurgie digestive J. Chir. 136 1999 117 123
45. K. Conlon, D. Labow, D. Leung, A. Smith, W. Jarnagin, and D. Coit Prospective randomized clinical trial of value of intraperitoneal drainage after pancreatic resection Ann. Surg. 234 2001 487 494
46. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch. Surg. 120 1985 899 903
47. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. Van Pel, M.L. Couvreur, and C.H. Veenhof Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann. Surg. 230 1999 776 782
48. J.P.D.J. Neoptolemos, D.D. Stocken, J. Almond, K. Link, H. Beger, and C. Bassi Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 2001 1576 1585
49. K.E.A.B. Bakkevold, O. Dahl, and B. Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study Eur. J. Cancer 29A 1993 698 703
50. F. Mornex, C. Partensky, and L. Bedenne Role of adjuvant chemoradiotherapy in the therapeutic strategy of exocrine adenocarcinoma of the pancreas Cancer Radiother 1 1997 542 546
51. J.D. Wayne, E.K. Abdalla, R.A. Wolff, C.H. Crane, P.W. Pisters, and D.B. Evans Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation Oncologist 7 2002 34 45